alexa Targeted Destruction Of HIV Positive Cells
ISSN 2155-6113

Journal of AIDS & Clinical Research
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

2nd International Conference on HIV/AIDS, STDs, & STIs
October 27-29, 2014 Embassy Suites Las Vegas, USA

Jyoti Sharma, Cleo Dodgen, Amanda Skepu and Mervin Meyer
Accepted Abstracts: J AIDS Clin Res
DOI: 10.4172/2155-6113.S1.009
Abstract
The rapidly expanding field of nanotechnology has vast potential to radically advance the treatment and prevention of HIV/ AIDS. Nanoparticles can provide improved drug delivery, by virtue of their small size, robustness, safety, multimodality or multifunctionality. Since HIV primarily infects CD4+ cells; we aim to use CD4 as a selectable target to deliver a pro-apoptotic protein to HIV infected cells using nanoparticles as carriers. The aim of this study was to develop a nanotechnology-based death inducing delivery system for the destruction of CD4+ HIV infected cells through the activation of caspase-3. A modified caspase-3 protein (Mut-3) was engineered, which is cleavable only by HIV-1 protease. Mut-3 can activate apoptosis in the presence of HIV-1 protease, consequently killing HIV positive cells. Mut-3 protein was conjugated to gold nanoparticles together with a CD4- targeting peptide. The efficacy of the gold nanoparticles was tested on CHO cells that were genetically engineered to express GFP labelled CD4 and HIV-1 protease. Mut-3 was expressed in bacterial cells and purified. CHO cells that stably over express CD4- GFP and HIV-1 protease were selected using Fluorescence Activated Cell Sorting. Dose response cell culture experiments showed that gold nanoparticles without Mut-3 and CD4- targeting peptide did not induce cell death in CHO cells, while gold nanoparticles that were conjugated with Mut-3 and the CD4- targeting peptide rapidly induced cell death in CHO cells. The results suggest that gold nanoparticles conjugated with Mut-3 and a CD4- targeting peptide could potentially induce apoptosis in HIV infected cells
Biography
Jyoti Sharma has completed her PhD degree in 2010 from Guru Nanak Dev University, Amritsar, India. Since 2010, she has been working as a Postdoctoral fellow in the Department of Biotechnology at University of Western Cape. She has been involved with various research projects: 1. Growth and feeding practices of Punjabi infants (India), 2. ?Obesity in Urban Middle Class of Punjab, India, Genetics of Autism (University of Western Cape) 3. Development of Protein Biomarker in Autism (University of Western Cape) 4. Molecular Genetics of Non Ketotic Hyperglycinemia among Vervet Monkeys (Medical Research Council). Her current project is ?Development of nanotechnology-based therapeutic approaches to treat HIV?. She has published 15 research papers in various reputed journals.
image PDF   |   image HTML
 
Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

[email protected]

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

[email protected]

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_m[email protected]

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

[email protected]

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001 Extn: 9042

 
© 2008-2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords